Source: News on Air
Context: The Central Drugs Standard Control Organisation (CDSCO), along with the National Regulatory Authority of India, has successfully met the international standards for vaccine regulations set by the World Health Organisation (WHO).
About Central Drugs Standard Control Organisation (CDSCO)
- Role: CDSCO serves as the National Regulatory Authority (NRA) of India for the medical devices and pharmaceutical industry under the Drugs & Cosmetics Act.
- Functionality: It operates under the Ministry of Health & Family Welfare, with the Drugs Controller General of India (DCGI) as its head.
- Headquarters: Based in New Delhi, India.
Key Responsibilities of CDSCO:
- Approval of new drugs: Evaluates and approves new drugs before they are released into the Indian market.
- Clinical trials oversight: Regulates the conduct of clinical trials to ensure safety and compliance with national standards.
- Drug standards: Establishes and maintains standards for drugs to ensure quality and consistency.
- Import control: Monitors and controls the quality of imported drugs to maintain safety standards within the country.
- Coordination with state authorities: Works in coordination with State Drug Control Organizations for the regulation and licensing of drugs.
- Specialized drug categories: Oversees the approval and regulation of critical drugs like blood products, I.V. Fluids, vaccines, and sera in collaboration with state regulators.
Significance of CDSCO’s achievement:
- Global compliance: India retains Maturity Level 3, indicating a high level of compliance with WHO’s vaccine regulatory standards.
- Pharmaceutical leadership: Reinforces India’s reputation as a leading global producer of affordable vaccines and generic medicines.
- Commitment to quality: Demonstrates India’s dedication to maintaining high standards in vaccine safety, efficacy, and quality, supporting global health initiatives.
Insta links:
